Arbutus Biopharma (ABUS) Treasury Shares (2023)

Arbutus Biopharma's (ABUS) quarterly Treasury Shares came in at $1.2 million in Q4 2023.

Arbutus Biopharma (ABUS) Treasury Shares (2023) Analysis & Trends

Arbutus Biopharma has disclosed Treasury Shares across 1 years of filings, most recently posting $1.2 million for Q4 2023.

Treasury Shares for Q4 2023 came in at $1.2 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was $1.2 million (changed N/A YoY), and the FY2023 annual result was $1.2 million, changed N/A from the prior year.
Treasury Shares came in at $1.2 million for Q4 2023 at Arbutus Biopharma.
In the past five years, Treasury Shares ranged from a high of $1.2 million in Q4 2023 to a low of $1.2 million in Q4 2023.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	1.48 Mn
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	700,000.00
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Arbutus Biopharma	882.62 Mn	882.62 Mn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2023	1.23 Mn
Dec 31, 2023	1.23 Mn